SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?


To: Rande Is who wrote (27970)6/19/2000 3:41:00 PM
From: carepedeum2000  Read Replies (2) | Respond to of 57584
 
you only regret it when your wrong, if it tanked, youd be feeling pretty good, i not only sold it, i shorted it (regretting that at this moment, will be stopped out soon)
anyway, if this market can close over 4000, maybe ill get a little more agressive, but very cautious at this point, just cant smell a "sustained" rally with vix at 22.5 and volume low, i just cant jump in right here (ok, ill nibble a litlle, just bought some bout at 34 15/16) but my vacation spanking last week has me gun shy i guess



To: Rande Is who wrote (27970)6/19/2000 4:20:00 PM
From: If only I'd held  Respond to of 57584
 
Gotta learn to hang on to your profitable portion Rande. Hard to cry about making money on free stock...even if it isn't the full position you had.

Hope all is well with you....have you seen my $9 RELL lately?



To: Rande Is who wrote (27970)6/19/2000 7:56:00 PM
From: baddtiming  Read Replies (1) | Respond to of 57584
 
Dont forget Gilder report will be out on the 21st. All fiber plays may get a boost from that as well:)



To: Rande Is who wrote (27970)6/19/2000 8:00:00 PM
From: DlphcOracl  Respond to of 57584
 
Rande and thread: any thoughts on PEB?

While the most visible biotechs have all nearly doubled since their mid-April lows, PEB has remained nearly flat and has not participated. It is a "picks-and shovels" play in the genomics sector, and supplies much of the equipment the genomics companies need for their research. It is profitable and has a low valuation (particularly for a biotech stock) with a P/E of 48. Either this is an overlooked gem or there is a reason this stock has been "dead money" for the past two months that I am not aware of. Any advice or comments on this stock would be appreciated.

Disclosure: I do not own nor am I short PEB, but am considering it for a LT purchase.